A Study To Assess Clinical Utility Of The Drug Tolerant Assay For Vedolizumab (Anser VDZ) And Clinical Response To Vedolizumab In Patients With Inflammatory Bowel Disease In Clinical Practice.
Latest Information Update: 10 Jan 2017
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 10 Jan 2017 New trial record